Hepatic resection: Effective treatment for primary and secondary tumors

Background. Hepatic resection is an accepted therapeutic modality for isolated colorectal metastases (CRM) and primary hepatobiliary cancers (PC). Controversy continues regarding the safety, efficacy, and appropriateness of resection for noncolorectal metastases (NCM). Methods. A retrospective revie...

Full description

Saved in:
Bibliographic Details
Published in:Surgery 2000-10, Vol.128 (4), p.686-693
Main Authors: Buell, Joseph F., Rosen, Seth, Yoshida, Atsushi, Labow, Daniel, Limsrichamrern, Somchai, Cronin, David C., Bruce, David S., Wen, Ming, Michelassi, Fabrizio, Millis, J.Michael, Posner, Mitchell C.
Format: Article
Language:English
Subjects:
Aged
Biliary Tract Neoplasms - pathology
Biliary Tract Neoplasms - secondary
Biliary Tract Neoplasms - surgery
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - secondary
Carcinoma, Hepatocellular - surgery
Cholangiocarcinoma - pathology
Cholangiocarcinoma - secondary
Cholangiocarcinoma - surgery
Colorectal Neoplasms - pathology
Female
Hepatectomy - mortality
Humans
Liver Neoplasms - pathology
Liver Neoplasms - secondary
Liver Neoplasms - surgery
Male
Middle Aged
Neoplasm Recurrence, Local
Prognosis
Retrospective Studies
Survival Analysis
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. Hepatic resection is an accepted therapeutic modality for isolated colorectal metastases (CRM) and primary hepatobiliary cancers (PC). Controversy continues regarding the safety, efficacy, and appropriateness of resection for noncolorectal metastases (NCM). Methods. A retrospective review of 167 resections in 160 patients was performed to evaluate the impact of demographics and perioperative data on survival and recurrence. Statistical analyses were performed by Student t test, analysis of variance, and Kaplan-Meier survival estimates. Results. Resections were performed for CRM, 110 of 167 (66%), NCM, 31 of 167 (19%), and PC, 26 of 167 (15%). The interval from primary to metastases was significantly longer in the NCM group than the CRM group (34.7 ± 45.1 vs 18.7 ± 23.7 months; P
ISSN:0039-6060
1532-7361
DOI:10.1067/msy.2000.108220